Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts

Laura Dean, Kimberley Ozano, Oluwatosin Adekeye, Ruth Dixon, Ebua Gallus Fung, Margaret Gyapong, Sunday Isiyaku, Karsor Kollie, Vida Kukula, Luret Lar, Eleanor MacPherson, Christine Makia, Estelle Kouokam Magne, Dum Buo Nnamdi, Theobald Mue Nji, Uduak Ntuen, Akinola Oluwole, Helen Piotrowski, Marlene Siping, Marlene Ntsinda TchoffoLouis Albert Tchuem Tchuenté, Rachael Thomson, Irene Tsey, Samuel Wanji, James Yashiyi, Georgina Zawolo, Sally Theobald

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)

Abstract

Individuals and communities affected by NTDs are often the poorest and most marginalised; ensuring a gender and equity lens is centre stage will be critical for the NTD community to reach elimination goals and inform Universal Health Coverage (UHC). NTDs amenable to preventive chemotherapy have been described as a ‘litmus test’ for UHC due to the high mass drug administration (MDA) coverage rates needed to be effective and their model of community engagement. However, until now highly aggregated coverage data may have

masked inequities in availability, accessibility and acceptability of medicines, slowing down the equitable achievement of elimination goals.

Original languageEnglish
Article numbere0007847
Pages (from-to)e0007847
JournalPLoS Neglected Tropical Diseases
Volume13
Issue number11
DOIs
Publication statusPublished - 21 Nov 2019

Fingerprint

Dive into the research topics of 'Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts'. Together they form a unique fingerprint.

Cite this